Piotrowski-Daspit, Alexandra S. https://orcid.org/0000-0003-4555-3234
Bracaglia, Laura G.
Eaton, David A. https://orcid.org/0009-0008-3701-2714
Richfield, Owen
Binns, Thomas C. https://orcid.org/0000-0003-1246-8957
Albert, Claire
Gould, Jared
Mortlock, Ryland D. https://orcid.org/0000-0001-9666-4394
Egan, Marie E.
Pober, Jordan S. https://orcid.org/0000-0001-5990-1071
Saltzman, W. Mark https://orcid.org/0000-0002-2163-549X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (UG3/UH3 HL147352, K99/R00 HL151806, K99/R00 HL157552)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R56 AI175206, R56 AI175206)
Cystic Fibrosis Foundation (EGAN641558, PIOTRO20F0, PIOTRO21F5, EGAN641558)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007276, T32 DK007276)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 17 July 2023
Accepted: 1 May 2024
First Online: 18 May 2024
Competing interests
: The authors declare the following competing interests: A.S.P., M.E.E. and W.M.S. are co-founders of and, at the time of preparing this manuscript, consultants for Xanadu Bio, Inc., W.M.S. is a member of the Board of Directors of Xanadu Bio, Inc., A.S.P., L.G.B., C.A., J.S.P., and W.M.S. are inventors on patent applications related to the work described here. The remaining authors declare no competing interests.